Rogers, E
Finally, sustained weight management through tirzepatide therapy can significantly decrease the likelihood of developing weight-related complications, such as obstructive sleep apnea, fatty liver disease, and certain types of cancers
[PMID: 2553668] PubMed record related to this compound for laboratory literature review
Compared with GLP-1 RAs, more participants receiving tirzepatide 15 mg discontinued treatment due to adverse events (OR 2.29 [95% CI 1.39, 3.75], I 2 0%), whereas no difference was evident for tirzepatide 5 mg and 10 mg (ESM Table 3)
Our histological findings of alveolar and bronchial epithelial degeneration and necrosis may be supported by these findings
Although this is a narrative review, we adopted a systematic approach for literature retrieval to enhance reproducibility